Information
5 Digital-ro 26-gil, Guro District, Seoul, South Korea
+82 2-6220-7721
-
-
Overview
- Summary
- NanoEntek is a leading company specializing in point-of-care diagnostics, developing, manufacturing, and selling life science research equipment, medical in-vitro diagnostic devices, and related consumables and solutions based on its core Bio-MEMS and Lab-on-a-Chip technologies. The company's Lab-on-a-Chip platform enables rapid and accurate biological analysis with minimal sample volumes. NanoEntek focuses on developing innovative products leveraging NT-IT-BT convergence technologies and expanding its global market presence.NanoEntek is a leading company specializing in point-of-care diagnostics, developing, manufacturing, and selling life science research equipment, medical in-vitro diagnostic devices, and related consumables and solutions based on its core Bio-MEMS and Lab-on-a-Chip technologies. The company's Lab-on-a-Chip platform enables rapid and accurate biological analysis with minimal sample volumes. NanoEntek focuses on developing innovative products leveraging NT-IT-BT convergence technologies and expanding its global market presence.
- Key Products/Technologies
- **Lab-on-a-Chip Technology**: A core technology combining MEMS (Micro-Electro-Mechanical-Systems) and Micro-Fluidics, involving the design of microchannels on plastic or glass microfluidic chips to precisely control biofluid flow, enabling various analyses in a short time with minimal sample amounts.**Lab-on-a-Chip Technology**: A core technology combining MEMS (Micro-Electro-Mechanical-Systems) and Micro-Fluidics, involving the design of microchannels on plastic or glass microfluidic chips to precisely control biofluid flow, enabling various analyses in a short time with minimal sample amounts.
- **Automated Cell Counters**: ADAM™ MC Plus (high-accuracy automated fluorescence cell counter with bright field and dual fluorescence channels (AO/DAPI), measuring total, viable, non-viable cells, viability, cell size, and aggregation), EVE™ HT FL (high-throughput fluorescence cell counter, processing up to 48 samples in 3 minutes with AO/DAPI staining), ADAM™ rWBC (residual White Blood Cell Counter, the world's first micro blood analyzer, designated as standard equipment for American Red Cross blood quality control), ADAMII™ CD34 (Fluorescence Stem Cell Counter), EVE™ Plus (automated cell counter), JuLI™ Stage (Real-time Live Cell Imaging System, offering time-lapse imaging and real-time monitoring, designed to fit into standard incubators).**Automated Cell Counters**: ADAM™ MC Plus (high-accuracy automated fluorescence cell counter with bright field and dual fluorescence channels (AO/DAPI), measuring total, viable, non-viable cells, viability, cell size, and aggregation), EVE™ HT FL (high-throughput fluorescence cell counter, processing up to 48 samples in 3 minutes with AO/DAPI staining), ADAM™ rWBC (residual White Blood Cell Counter, the world's first micro blood analyzer, designated as standard equipment for American Red Cross blood quality control), ADAMII™ CD34 (Fluorescence Stem Cell Counter), EVE™ Plus (automated cell counter), JuLI™ Stage (Real-time Live Cell Imaging System, offering time-lapse imaging and real-time monitoring, designed to fit into standard incubators).
- **Point-of-Care (POCT) Immunoassay Systems**: FREND™ System (microfluidic immunofluorescence analyzer, supporting various diagnostic items including PSA Plus, TSH, Free T4, Testosterone, Vitamin D, and COVID-19 Ag/Ab tests), BUDDI™ (Rapid Diagnostic Test Analyzer).**Point-of-Care (POCT) Immunoassay Systems**: FREND™ System (microfluidic immunofluorescence analyzer, supporting various diagnostic items including PSA Plus, TSH, Free T4, Testosterone, Vitamin D, and COVID-19 Ag/Ab tests), BUDDI™ (Rapid Diagnostic Test Analyzer).
- **Gene Transfection System**: ExTransfection™ Electroporation System (a compact benchtop electroporation system designed for efficient gene transfection while maintaining high cell viability).**Gene Transfection System**: ExTransfection™ Electroporation System (a compact benchtop electroporation system designed for efficient gene transfection while maintaining high cell viability).
- **Consumables**: Disposable Hemocytometers such as C-Chip (4-channel, 2-channel) and S-Chip (for sperm analysis), along with various reagents and kits for disease diagnosis and research.**Consumables**: Disposable Hemocytometers such as C-Chip (4-channel, 2-channel) and S-Chip (for sperm analysis), along with various reagents and kits for disease diagnosis and research.
- Core Advantages
- Possession of core Bio-MEMS technology, integrating Micro-Electro-Mechanical-Systems (MEMS) with biotechnology, and a Lab-on-a-Chip platform technology. Recognition as one of the few companies globally to successfully commercialize and mass-produce Lab-on-a-Chip technology, establishing a significant technological advantage. The ability to implement laboratory processes on a fingernail-sized microfluidic chip, contributing significantly to medical and bioengineering advancements.Possession of core Bio-MEMS technology, integrating Micro-Electro-Mechanical-Systems (MEMS) with biotechnology, and a Lab-on-a-Chip platform technology. Recognition as one of the few companies globally to successfully commercialize and mass-produce Lab-on-a-Chip technology, establishing a significant technological advantage. The ability to implement laboratory processes on a fingernail-sized microfluidic chip, contributing significantly to medical and bioengineering advancements.
- Leadership in the global market, achieving a 30% market share with the world's first compact automated cell counter. Validation of product excellence and reliability through the selection of ADAM-rWBC as the standard equipment for blood quality control (QC) by the American Red Cross. Establishment of an extensive global partner network with over 249 distributors worldwide.Leadership in the global market, achieving a 30% market share with the world's first compact automated cell counter. Validation of product excellence and reliability through the selection of ADAM-rWBC as the standard equipment for blood quality control (QC) by the American Red Cross. Establishment of an extensive global partner network with over 249 distributors worldwide.
- A comprehensive product portfolio encompassing life science research equipment, in-vitro diagnostic medical devices, and related consumables and solutions. Provision of innovative and user-friendly products across various fields, including automated cell counters, immunoassay systems, real-time cell imaging systems, and gene delivery systems. Expansion into digital healthcare services by integrating AI and big data technologies.A comprehensive product portfolio encompassing life science research equipment, in-vitro diagnostic medical devices, and related consumables and solutions. Provision of innovative and user-friendly products across various fields, including automated cell counters, immunoassay systems, real-time cell imaging systems, and gene delivery systems. Expansion into digital healthcare services by integrating AI and big data technologies.
- Strong technological competitiveness evidenced by over 100 domestic and international patents filed and registered related to NT-IT-BT (nanotechnology-information technology-biotechnology) convergence technology. Proof of nano-bio convergence technology prowess through the sale of patent rights and exclusive license for the Microporator gene transfection system to a global company for 13 million USD. A continuous commitment to technological innovation through ongoing research and development investments.Strong technological competitiveness evidenced by over 100 domestic and international patents filed and registered related to NT-IT-BT (nanotechnology-information technology-biotechnology) convergence technology. Proof of nano-bio convergence technology prowess through the sale of patent rights and exclusive license for the Microporator gene transfection system to a global company for 13 million USD. A continuous commitment to technological innovation through ongoing research and development investments.
- Securing 75 US FDA 510(k) clearances and obtaining US FDA approvals for a total of nine key products, including ADAM-rWBC, ADAMII-CD34, and FREND™ PSA Plus, TSH, Free T4, Testosterone, and Vitamin D. Receipt of European CE-IVD certification for its COVID-19 antigen diagnostic kit (FREND COVID19 Ag), facilitating entry into the European market. These regulatory approvals signify international recognition of the products' safety and efficacy.Securing 75 US FDA 510(k) clearances and obtaining US FDA approvals for a total of nine key products, including ADAM-rWBC, ADAMII-CD34, and FREND™ PSA Plus, TSH, Free T4, Testosterone, and Vitamin D. Receipt of European CE-IVD certification for its COVID-19 antigen diagnostic kit (FREND COVID19 Ag), facilitating entry into the European market. These regulatory approvals signify international recognition of the products' safety and efficacy.
- Development of products suitable for diverse healthcare settings requiring point-of-care diagnostics, such as small to medium-sized hospitals, emergency rooms (EDs) and intensive care units (ICUs) in major cities, and primary care facilities. Contribution to reducing healthcare disparities and socio-economic medical costs through the establishment of u-healthcare systems, enabling proactive medical services. Entry into the beauty tech sector through collaboration with L'Oréal, securing a new growth engine.Development of products suitable for diverse healthcare settings requiring point-of-care diagnostics, such as small to medium-sized hospitals, emergency rooms (EDs) and intensive care units (ICUs) in major cities, and primary care facilities. Contribution to reducing healthcare disparities and socio-economic medical costs through the establishment of u-healthcare systems, enabling proactive medical services. Entry into the beauty tech sector through collaboration with L'Oréal, securing a new growth engine.
- Target Industrie
- Life Science Research (cell counting, imaging, gene transfection, etc.)Life Science Research (cell counting, imaging, gene transfection, etc.)
- In-vitro Diagnostic Medical Devices (Point-of-Care Testing (POCT), immunoassay, blood cell diagnostics, companion diagnostics, chemical diagnostics, etc.)In-vitro Diagnostic Medical Devices (Point-of-Care Testing (POCT), immunoassay, blood cell diagnostics, companion diagnostics, chemical diagnostics, etc.)
- Pharmaceutical and Biotechnology Industries (drug discovery, cell therapy research, etc.)Pharmaceutical and Biotechnology Industries (drug discovery, cell therapy research, etc.)
- Blood Quality Control (standard equipment for American Red Cross blood quality control)Blood Quality Control (standard equipment for American Red Cross blood quality control)
- Beauty Tech Industry (development of personalized skincare solutions)Beauty Tech Industry (development of personalized skincare solutions)
- Major Markets
- United Arab Emirates (scheduled to participate in WHX Labs Dubai 2026 exhibition)United Arab Emirates (scheduled to participate in WHX Labs Dubai 2026 exhibition)
- South Korea, ChinaSouth Korea, China
- Germany, Belgium (scheduled to participate in SFTS 2025 exhibition)Germany, Belgium (scheduled to participate in SFTS 2025 exhibition)
- United StatesUnited States
- Certifications/Patents
- Over 100 domestic and international patents filed and registered related to NT-IT-BT (nanotechnology-information technology-biotechnology) convergence technology.Over 100 domestic and international patents filed and registered related to NT-IT-BT (nanotechnology-information technology-biotechnology) convergence technology.
- 75 US FDA 510(k) clearances obtained.75 US FDA 510(k) clearances obtained.
- US FDA approved products: ADAM-rWBC, ADAMII-CD34, FREND™ PSA Plus, TSH, Free T4, Testosterone, Vitamin D, totaling nine types.US FDA approved products: ADAM-rWBC, ADAMII-CD34, FREND™ PSA Plus, TSH, Free T4, Testosterone, Vitamin D, totaling nine types.
- European CE-IVD certification: COVID-19 antigen diagnostic kit (FREND COVID19 Ag).European CE-IVD certification: COVID-19 antigen diagnostic kit (FREND COVID19 Ag).
- Key patent registrations include: Sampler-related patents (sample dilution and quantitative dispensing), Japanese patent for microfluidic analysis chip (OCA film bonding method), US patent for sample pretreatment system and its control method (enhancing reliability and convenience of point-of-care diagnostics), and patent for fluid sample analysis chip (for disease diagnosis and monitoring biochips).Key patent registrations include: Sampler-related patents (sample dilution and quantitative dispensing), Japanese patent for microfluidic analysis chip (OCA film bonding method), US patent for sample pretreatment system and its control method (enhancing reliability and convenience of point-of-care diagnostics), and patent for fluid sample analysis chip (for disease diagnosis and monitoring biochips).
Introduction
Location
5 Digital-ro 26-gil, Guro District, Seoul, South Korea
클릭하여 위치 살펴보기
